Gilead Sciences (GILD) has prevailed in a long-running legal battle after the California Supreme Court ruled in the company’s favour over its tenofovir-based HIV treatments. The decision brings years of complex litigation
Curium has agreed to acquire all outstanding shares of Lantheus Holdings (LNTH) in a transaction that could be worth as much as $8 billion. Under the terms of the deal, Lantheus shareholders
More
The Internal Revenue Service has raised its optional standard mileage rate for business use of a personal vehicle to 76 cents per mile, effective July 1, 2026. The increase from 72.5 cents
More
The New York Times has published a detailed account of turmoil inside Paul, Weiss, revealing how the firm became entangled in political pressure and internal disputes. Scott Barshay, now running the firm,
More
Dividend investing remains one of the most reliable strategies for building lasting wealth through market cycles and economic uncertainty. Investors seeking steady income often turn to dividend-paying stocks as a way to
More
Clarkson (CKN), the global shipbroking and shipping services group, pushed sharply higher in London trading after releasing results that impressed investors and analysts alike. The FTSE 250 firm, widely regarded as a
More
Otsuka’s Voyxact Halts Kidney Function Decline In Phase 3 IgAN Trial, Strengthening FDA Approval Bid
Otsuka has reported positive full results from its Phase 3 VISIONARY trial, showing its drug Voyxact stabilised kidney function in adults with IgA nephropathy over two years. Voyxact, known clinically as sibeprenlimab-szsi,
More
The Office of Management and Budget published the Trump Administration’s 2026 Unified Agenda in July, outlining regulatory priorities across multiple federal agencies. Among the most significant entries, the USDA’s portion of the
More
Fauci’s appearance before Congress drew sharp criticism from conservative commentators after he repeatedly declined to answer questions under oath. The former director of the National Institute of Allergy and Infectious Diseases invoked
More
The FTSE 100 closed lower on Monday as a sharp sell-off in AstraZeneca weighed heavily on the index, overshadowing broader optimism across European markets. The FTSE 100 index ended the session down
More
Manufacturing Surge Puts Fed Rate Hike Firmly On The Table As Inflation Fears Eclipse Pandemic Chaos
A landmark jump in U.S. factory activity is signalling the economy may be shaking off the weight of tariffs, but a troubling inflation picture is intensifying pressure on policymakers. The Institute for
More